- Report
- April 2024
- 50 Pages
Global
From €2562EUR$2,650USD£2,201GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- January 2024
- 145 Pages
Global
From €3770EUR$3,899USD£3,238GBP
- Report
- November 2023
- 140 Pages
Global
From €2416EUR$2,499USD£2,075GBP
- Book
- July 2023
- 1568 Pages
- Book
- July 2015
- 328 Pages
Moxidectin is a macrocyclic lactone anthelmintic used in animal pharmaceuticals to treat parasites in livestock, horses, and companion animals. It is a broad-spectrum antiparasitic agent that is effective against a wide range of parasites, including gastrointestinal nematodes, lungworms, and mites. Moxidectin is administered orally, topically, or by injection, depending on the species and the type of parasite. It is also used in combination with other antiparasitic agents to increase efficacy.
Moxidectin is a popular choice for animal pharmaceuticals due to its safety profile and efficacy. It is well tolerated by animals and has a low risk of adverse reactions. It is also effective against parasites that are resistant to other antiparasitic agents.
Some companies in the Moxidectin market include Merial, Zoetis, Elanco, Bayer, and Virbac. Show Less Read more